PlainRecalls
FDA Drug Moderate Class II Terminated

Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92

Reported: November 13, 2013 Initiated: October 9, 2013 #D-66458-1

Product Description

Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92

Reason for Recall

Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.

Details

Recalling Firm
Sandoz, Inc
Units Affected
692 bottles (90 count)
Distribution
Nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92. Recalled by Sandoz, Inc. Units affected: 692 bottles (90 count).
Why was this product recalled?
Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 13, 2013. Severity: Moderate. Recall number: D-66458-1.